For example, nanoparticles loaded with acriflavine or siRNA targeting HIF-1α are coated with hypoxia-sensitive polymers that degrade under low oxygen levels, ensuring targeted delivery to hypoxic tumor cells (87, 88). The gene discussed is HIF1A; the disease is neoplasm.